Introduction
============

Lung cancer is one of the most commonly diagnosed malignancies in the world, accounting for 17.6% (1.18 million people) of worldwide cancer-related deaths annually.[@b1] In China, national death survey and cancer registration data shows that lung cancer is also the leading cause of cancer death in most Chinese cities.[@b2] Lung cancer is indeed a major global public health challenge. However, to date, the precise mechanisms of lung carcinogenesis are still not fully understood. A previous study showed that low-penetrance susceptibility genes in combination with environmental factors were of importance in lung cancer development and contributed to lung cancer risk.[@b3] Therefore, further studies in this field could lead to better understanding of lung cancer risk and susceptibility genes.

Toward this end, our research focuses on murine double minute-2 (*MDM2*), which is a negative regulator of p53 tumor suppressor. *MDM2* protein functions as an E3 ubiquitin ligase that recognizes the N-terminal trans-activation domain of p53 protein, and inhibitor of p53 transcriptional activation. *MDM2* protein plays an important role in regulation of p53 pathway activity. A single nucleotide polymorphism (SNP) of *MDM2*-rs2279744 was identified as a functional SNP with a T-to-G transversion and has been proven to increase the affinity of the transcriptional activator Sp1 and lead to expression of higher *MDM2* messenger ribonucleic acid (mRNA) and protein levels, subsequently attenuating p53 pathway activity.[@b4] The elevated levels of *MDM2* protein in carriers of the G-allele will inhibit the p53-induced apoptotic responses to DNA-damage, thereby resulting in genetic instability (such as gene mutations in the cells) and eventually leading to tumorigenesis at a young age.[@b5]

However, the association between *MDM2*-rs2279744 SNP and lung cancer risk seems plausible; for example, Hu *et al*.[@b6] and Pine *et al*.[@b7] reported that there was no significant association between *MDM2* SNP309 variant genotypes and lung cancer risk, whereas studies conducted by Zhang *et al*.[@b8] and Lind *et al*.[@b9] showed that the G-allele in the *MDM2* promoter was associated with a higher lung cancer risk. Additionally, Chua *et al*. showed that the T-allele in the *MDM2* promoter increased lung cancer risk.[@b10] Other studies have demonstrated that *MDM2*-rs2279744 SNP is associated with lung cancer risk at an early age.[@b11],[@b12] Thus, this case-control study investigated this functionally important *MDM2*-rs2279744 SNP in our hospital for association with lung cancer risk, together with other clinicopathological and epidemiologic data from lung cancer patients, as other factors, such as sociodemographic information, medical and family history, and lifestyle data, may also play a role in lung carcinogenesis.[@b13]--[@b19]

Patients and methods
====================

Study population
----------------

The study was approved by the Ethics Committee of the First Hospital of Jilin Medical University, and conducted according to the Declaration of Helsinki Principles. All subjects signed a written informed consent form. This hospital-based case-control study recruited a total of 1000 subjects from Northeastern China between January 2010 and December 2012. Patients who met the following criteria were included in the study: (i) a minimum of 18 years of age; (ii) primary lung cancer confirmed by pathology; (iii) Han descent; (iv) reside in Northeastern China for at least 10 years; and (v) no radiotherapy or chemotherapy performed before blood withdrawal. Patients with any of the following conditions were excluded: (i) secondary (metastatic) lung cancer; (ii) double or multiple primary cancers; and (iii) relapse after operation. Healthy controls had no cancer history within five years of the interview date. These healthy controls were randomly selected individuals who received routine physical examinations in our hospital and were matched to cases by age, gender, and residential area.

Diagnostic criteria and data collection
---------------------------------------

Standardized interviews were conducted by well-trained interviewers at either the hospital or at the homes of the studied subjects. Sociodemographic information, medical and family history, lifestyle data, and cancer diagnosis were recorded (Table [1](#tbl1){ref-type="table"}). Risk factors and peripheral blood lymphocytes were collected for the time prior and up to the index date (i.e. the time of diagnosis for cases and the interview date for controls). However, there were no data available on exposure to asbestos for analysis.

###### 

Univariate analysis of the risk factors in cases and controls

  Characteristic                         Case (*n* = 500 \[%\])         Control (*n* = 500\[%\])   *P-*value     
  -------------------------------------- ------------------------------ -------------------------- ------------- -------
  Gender                                 Male                            305 (61.0)                 302 (60.4)   0.846
  Female                                  195 (39.0)                     198 (39.6)                              
  Age (years)                            \<30                             2 (0.4)                    5 (1.0)     0.421
  30--39                                   14 (2.8)                       16 (3.2)                               
  40--49                                   64 (12.8)                      70 (14.0)                              
  50--59                                  176 (35.2)                     196 (39.2)                              
  60--69                                  174 (34.8)                     148 (19.7)                              
  ≥70                                      70 (14.0)                      65 (13.0)                              
  Education                              Junior high school and lower    318 (63.6)                 130 (26.0)   0.000
  High school                              97 (19.4)                      144 (28.8)                             
  Greater than high school                 85 (17.0)                      226 (45.2)                             
  Smoking (pack-years)                   14.25 (0.0--36.0)              0.00 (0.0--6.9)            0.000         
  Occupational exposure                  Absent                          398 (79.6)                 473 (94.6)   0.000
  Pesticide                              Present                         102 (20.4)                 27 (5.4)     
  Exposure Gasoline /diesel              Absent                          487 (97.4)                 496 (99.2)   0.037
  Present                                  13 (2.6)                       4 (0.8)                                
  Exposure to Ink                        Absent                          493 (98.6)                 497 (99.4)   0.217
  Present                                  7 (1.4)                        3 (0.6)                                
  Cooking emissions (total dish-years)   Absent                          244 (48.8)                 250 (50.0)   0.003
  ≤50                                     149 (29.8)                     152 (30.4)                              
  51--100                                  61 (12.2)                      80 (16.0)                              
  101--150                                 46 (9.2)                       18 (3.6)                               
  Pneumonia history                      Absent                          477 (95.4)                 490 (98.0)   0.025
  Present                                  23 (4.6)                       10 (2.0)                               
  COPD history                           Absent                          449 (89.8)                 489 (97.8)   0.000
  Present                                  51 (10.2)                      11 (2.2)                               
  Pulmonary tuberculosis history         Absent                          470 (94.0)                 486 (97.2)   0.016
  Present                                  30 (6.0)                       14 (2.8)                               
  Bronchial asthma history               Absent                          488 (97.6)                 495 (99.0)   0.097
  Present                                  12 (2.4)                       5 (1.0)                                
  Cancer family history                  Absent                          330 (66.0)                 397 (79.4)   0.000
  Present                                 170 (34.0)                     103 (20.6)                              
  BMI (kg/m^2^)                          \<18.5                           49 (9.8)                   15 (3.0)    0.000
  18.5--24                                302 (60.4)                     230 (46.0)                              
  ≥24                                     149 (29.8)                     255 (51.0)                              

Including large cell, mixed cell carcinoma, or undifferentiated carcinoma. BMI, body mass index; COPD, chronic obstructive pulmonary disease.

Genotyping and quality control
------------------------------

Genomic DNA was extracted from the peripheral blood lymphocytes of all subjects. MassArray (Sequenom, Inc., San Diego, CA, USA) was used for genotyping all markers by using allele specific matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Primers and multiplex reactions were designed using the RealSNP.com website. All lung cancer patients and healthy controls were genotyped for MDM2-rs2279744 polymorphisms. Concordance among the three genomic control DNA samples presented in duplicate was 100%. Of SNPs with genotyping data, the call rate was \>95%.

Statistical analysis
--------------------

The Hardy-Weinberg equilibrium was performed to analyze the balance of case and control using a goodness-of-fit chi-square (χ^2^) test. The univariate χ^2^ test was used to determine genotype frequencies with observed genotype frequencies in healthy controls versus lung cancer cases and association between *MDM2*-rs2279744 SNP and clinicopathological data from lung cancer patients. Multivariate logistic regression analysis was used to assess the association between risk factors (SNPs were included) and lung cancer risk. All categorical variables were set as dummy variables. The first category of each environmental variable was selected as the baseline, as well as the low-risk allele of each locus. All analysis was conducted using SPSS v19.0 software (SPSS, Inc., Chicago, IL, USA). A *p*-value of less than 0.05 was considered statistically significant.

Results
=======

Univariate analysis of *MDM2*-rs2279744 polymorphism for association with lung cancer risk
------------------------------------------------------------------------------------------

A total of 1000 subjects (i.e. 500 incident lung cancer cases and 500 healthy controls) were recruited for genotyping of *MDM2*-rs2279744. Univariate analysis revealed that lung cancer occurred more frequently in individuals with a family history of cancer, history of chronic obstructive pulmonary disease (COPD), pulmonary tuberculosis, pneumonia, low body mass index (BMI), tobacco smoking, occupational exposure to pesticides, gasoline, or diesel, and exposure to cooking emissions, as well as a low education level (Table [1](#tbl1){ref-type="table"}).

Furthermore, our data also showed that the genotype distribution of *MDM2*-rs2279744 polymorphism was followed by Hardy-Weinberg equilibrium (*P* \> 0.05). *MDM2* G/G genotype occurred in 25.8%, G/T genotype in 48.8%, and T/T genotype in 25.4% of lung cancer cases, with a similar distribution in the healthy control (*P* \> 0.05). Univariate analysis showed that when comparing G/G with T/T + T/G genotypes, the G/G had a tendency toward a higher incidence of lung cancer in the recessive model (*P* = 0.043; Table [2](#tbl2){ref-type="table"}). However, there were no significant differences in the dominant, additive, or multiplicative models.

###### 

Association of *MDM2*-rs2279744 polymorphism with lung cancer risk analyzed by univariate analysis

                         Genotype    Exp (B)          95% CI           *P*-value
  ---------------------- ----------- ---------------- ---------------- -----------
  Additive model         T/T         1                Reference        ---
  G/T                    0.932       (0.691--1.258)   0.645            
  G/G                    1.295       (0.906--1.849)   0.156            
  Dominant model         T/T         1                Reference        ---
  G/G + G/T              1.032       (0.777--1.370)   0.828            
  Recessive model        T/T + G/T   1                Reference        ---
  G/G                    1.357       (1.009--1.824)   0.043            
  Multiplicative model   G-allele    1.131            (0.947--1.351)   0.174

CI, confidence interval; *MDM2*, mouse double minute-2.

Multivariate analysis of *MDM2*-rs2279744 polymorphism for association with lung cancer risk
--------------------------------------------------------------------------------------------

Multivariate analysis showed a significantly increased lung cancer risk in individuals with a lower education level, lower BMI, cancer family history, prior diagnosis of COPD and pneumonia, exposure to pesticide or gasoline/diesel, tobaccco smoking, heavy cooking smoke, and *MDM2*-rs2279744 SNP. The latter was still a significant risk factor for lung cancer, even after incorporating environmental and lifestyle factors (Table [3](#tbl3){ref-type="table"}).

###### 

Multivariate risk model with adjusted odds ratios and 95% CI

  Risk factors                         Exp (B)   95% CI          *P*-value
  ------------------------------------ --------- --------------- -----------
  Education level                      0.000                     
  Junior high school and lower         1.00      Reference       ---
  High school                          0.307     0.211--0.446    0.000
  Greater than high school             0.195     0.134--0.284    0.000
  Smoking (pack-years)                 1.032     1.023--1.041    0.000
  Occupational exposure to pesticide                             
  Absent                               1.00      Reference       ---
  Present                              1.700     1.024--2.824    0.040
  Exposure to gasoline /diesel                                   
  Absent                               1.00      Reference       ---
  Present                              5.065     1.430--17.945   0.012
  Cooking smoke (total dish-years)     0.004                     
  ≤50                                  1.00      Reference       ---
  51--100                              1.417     0.998--2.011    0.869
  101--150                             0.962     0.610--1.519    0.006
  \>150                                2.511     1.301--4.846    0.026
  COPD history                                                   
  Absent                               1.00      Reference       ---
  Present                              4.162     1.950--8.883    0.000
  Pneumonia history                                              
  Present                              1.00      Reference       ---
  Absent                               0.369     0.151--0.902    0.029
  Cancer family history                                          
  Absent                               1.00      Reference       ---
  Present                              2.024     1.442--2.842    0.000
  BMI (kg/m^2^)                        0.000                     
  \<18.5                               1.00      Reference       
  18.5--24                             0.426     0.215--0.843    0.014
  ≥24                                  0.215     0.107--0.432    0.000
  rs2279744                                                      
  T/T + G/T                            1.00      Reference       ---
  G/G                                  1.475     1.153--1.887    0.002

BMI, body mass index; CI, confidence interval; COPD, chronic obstructive pulmonary disease.

Association of *MDM2*-rs2279744 SNP with clinicopathological patient data
-------------------------------------------------------------------------

We also evaluated *MDM2*-rs2279744 SNP for association with the clinicopathological data from lung cancer patients. We did not find any statistically significant associations (Table [4](#tbl4){ref-type="table"}).

###### 

Association of *MDM2*-rs2279744 SNP with the clinicopathological data from lung cancer patients

  Characteristic                                      G/G (*n* = 231)   T/T + G/T (*n* = 769)   *P*-value   
  --------------------------------------------------- ----------------- ----------------------- ----------- -------
  Gender                                              Male              141                     466         0.965
  Female                                              90                303                                 
  Age (years)                                         \<30              3                       4           0.530
  30--39                                              5                 25                                  
  40--49                                              36                98                                  
  50--59                                              85                287                                 
  60--69                                              75                247                                 
  ≥70                                                 27                108                                 
  BMI (kg/m^2^)                                       \<18.5            8                       56          0.101
  18.5--24                                            130               402                                 
  ≥24                                                 93                311                                 
  Histology types                                     Squamous cell     35                      106         0.946
  Adenocarcinoma                                      48                128                                 
  Small cell                                          31                95                                  
  Other carcinomas[\*](#tf4-1){ref-type="table-fn"}   15                42                                  

^\*^Including large cell, mixed cell carcinoma, or undifferentiated carcinoma. BMI, Body mass index; *MDM2*, mouse double minute-2; SNP, single nucleotide polymorphism.

Discussion
==========

Several study models have been developed to predict the individual risk for lung cancer using patient characteristics, epidemiologic, social, and clinical risk factors.[@b13]--[@b19] Our current study genotyped *MDM2*-rs2279744 SNP in a Northeastern Chinese population to associate lung cancer risk, together with other clinicopathological and epidemiologic factors. We found that there were several factors associated with lung cancer risk, including family history of cancer, COPD, pneumonia, occupational exposure to pesticide or gasoline/diesel, duration of tobacco smoking, and heavy cooking smoke, as well as lower education level or BMI. Our current data are consistent with the findings of previous studies.[@b13]--[@b19] Furthermore, our current study also showed that the *MDM2*-rs2279744 G/G genotype was associated with lung cancer risk in recessive model analysis and was still associated with lung cancer risk after incorporating environmental and lifestyle factors. Thus, this study has demonstrated that the *MDM2*-rs2279744 G/G genotype is associated with lung cancer risk. Molecularly, *MDM2*-rs2279744 is a functional SNP and is able to regulate *MDM2* protein expression, that is, the *MDM2*-rs2279744 G-allele results in higher levels of *MDM2* mRNA and protein, which, in turn, attenuate the p53 stress response pathway through directly blocking p53 transcriptional activity and mediating p53 protein degradation.[@b4],[@b20] The attenuation of p53 pathway activity will lead to lung carcinogenesis, which has been confirmed in an animal experiments, that is, suppression of the p53 pathway increased the lung tumor multiplicity in p53-mutated mice after they were exposed to tobacco smoke.[@b21],[@b22] A predisposition to cancer has been presented in *MDM2* overexpressed mice.[@b23]

Furthermore, *MDM2*-rs2279744 SNP was not associated with any clinicopathological data from lung cancer patients. This was a surprising result, but mechanistically it may be rationalized that p53 expression is a result of p53 mutations in most lung cancers. In this case, the p53 gene pathway was already altered and the increased *MDM2* expression as a result of *MDM2*-rs2279744 G/G SNP did not contribute to tumor progression. Indeed, in previous studies, the p53 rs1042522 C-allele SNP was associated with reduced apoptotic potential in lung cancer patients compared to the p53 G-allele, and might modulate lung cancer risk, cancer progression, and/or response to treatment,[@b24]--[@b26] indicating that p53 plays an important role in the suppression of lung carcinogenesis.

There were a number of limitations in our study. Firstly, the *MDM2*-TP53 interaction played a pivotal role in regulation of the cell-cycle checkpoint, DNA repair, and apoptotic cell death. A common SNP at p53 rs1042522 has also been found to be of functional significance, with the C-allele having reduced the apoptotic potential compared to the G-allele, which may modulate the lung cancer risk, progression, and/or response to treatment.[@b24]--[@b26] Our current data would be much stronger in the prediction of lung cancer risk if we would combine this p53 SNP with *MDM2*-rs2279744 G/G SNP. Secondly, our current data may not be generalizable to other populations because this is a hospital-based case-control study, and, thus, needs external validation in other populations. Thirdly, our current analyses did not include all epidemiological factors, such as exposure to asbestos. Finally, this was a retrospectively designed study, and the sample size is relatively small; therefore, the results need to be validated by a large-scale and prospective design study.

Conclusion
==========

In conclusion, *MDM2*-rs2279744 is associated with lung cancer risk in Northeastern Chinese population.
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